Welcome Christine!

Researchers lay foundation for drug development against BK polyomavirus

HIPS team develops strategy against Pseudomonas aeruginosa

HIPS researchers are opening up new avenues for the treatment of multi-resistant pathogens

Researchers develop a new genetic method for the production of new active ingredients in bacteria

Andreas Keller, Josef Penninger and Marc Stadler receive award as most cited in their fields

New active compounds inspired by a bacterium

How citizens can contribute to the fight against antimicrobial resistance

HIPS will grow to over 330 researchers by 2029 and presents designs for new research building

The hidden pitfalls of data leakage in pharmaceutical research

Genetic analysis of bacteria from humans and animals paves the way for new active ingredients

Investigation of the symbiosis between bacteria and birds leads to the discovery of new natural products with antimicrobial properties

Leibniz ScienceCampus "Living Therapeutic Materials" is entering its second funding phase after four years of successful research.

First working meeting of the Parliamentary Group against Antimicrobial Resistance (PKAMR) on 11 September 2024 in Berlin

Martin Empting receives EFMC Young Medicinal Chemist in Academia 2024 Runner-Up Award

The PharmaScienceHub is the new cooperation platform of Saarland University and HIPS.

New synthetic biology technology enables better research and use of odilorhabdins in the future

New HIPS spin-off company offers a library of novel small molecules

Citizen Science at HIPS uncovers new natural substances against malaria pathogens

HIPS researchers develop innovative model for drug testing against hair follicle infections

MICROBELIX pop-up laboratory at the Günther von Bünau WildnisCamp Saarbrücken on 19 and 20 July 2024

HIPS team wins Saarland research prize "Alternatives to animal testing"

Interview with the first candidate of the Young AcademiXX program

Researcher honored by HZI and Technische Universität Braunschweig heads affiliated research group at HIPS

Japanese fund supports research into the treatment of filarial infections

HIPS researchers discover new family of bacteria with high pharmaceutical potential

Medicinal Chemist is honored for her work in the field of anti-infectives

HIPS researcher explains how active substances can be identified from microbiota

HIPS student researcher Alexander Becker wins state competition "Jugend forscht" in the field of biology

Saarbrücken research project on new antibiotics receives ERC Proof of Concept funding

Daniel Krug presents the HIPS citizen science project in the Helmholtz Association's research podcast

Research on protein evolution provides new starting points for the rapid and targeted development of future drugs

Bioinformaticians decode essential biochemical signaling pathways in the transmission of stimuli in the brain

Participants jointly design the work program of the interdisciplinary collaboration platform

Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) seeks planning office to implement its spatial expansion

Saarbrücken research project on new antibiotics against bacterial pneumonia receives CARB-X funding

Saarbrücken-based research project on new drugs against infectious diseases receives support from Bill & Melinda Gates Foundation

Researchers from TWINCORE, HZI and HIPS discover promising drug candidate

In a joint statement, the organizations emphasize the importance of a strong democracy and an open society for Germany's future viability

Saarland University successfully clears first hurdle with draft proposal for drug research

BioVersys AG and Helmholtz Centre for Infection Research join forces to accelerate AMR research and development 

HIPS bioinformatics team publishes comprehensive databases

HIPS and DZIF researchers improve activity and pharmacokinetic properties of the drug

Federal Ministry of Education and Research funds German-Ukrainian project to establish a core of excellence in Ukraine

HIPS researchers provide insights into two current research projects

Researchers establish green pharmaceutical production from wood waste

Klaus Faber Foundation supports successful call defence of Prof Olga Kalinina by HIPS and Saarland University

HIPS scientist increased the efficacy of clinically used antibiotics

HIPS Researchers organize symposium with leading international experts from the field

Head of Department Andreas Keller presents his Bioinformatics Department.

Scientists apply innovative liquid crystals for delivering drugs through the skin

Interdisciplinary research project wins funding award for citizen science

Innovative malaria project enters next round with GO-Bio initial funding

Finding the needle in the haystack of molecules produced by nature

The ISAM Conference in Saarbrücken

HIPS director is honoured for his exceptional merit in industrial microbiology and biotechnology

New collaboration platform aims to accelerate the development of innovative active substances

Saarbrücken citizen science project combines antibiotics research with nature conservation

Researchers print bacterial biofilms on human lung cells to study chronic lung infections

Study shows efficacy of the natural product chlorotonil A against dormant stages of the Clostridioides difficile bacterium

Reducing the number of animal studies

Discovery of two novel classes of natural products with activity against RNA viruses

Attracting a high-level audience of researchers, the conference will provide a stimulating platform to discuss the state of the art in drug discovery with academic experts and…

Helmholtz Association funds interdisciplinary collaboration between two of its Research Fields

A research team from Saarbrücken develops a novel lung cell line for testing drugs

HIPS scientist receives funding to develop new antibiotics

Saarbrücken researchers use bacterial communication as a target for new drugs

Researchers from Saarbrücken and Freiburg develop promising active ingredient to combat multi-resistant bacteria.

Improved darobactin derivatives show activity against carbapenem-resistant hospital germs

New class of active agents to combat multi-resistant pathogens to be developed to market maturity in the coming years

Corramycin is a new compound with activity against Gram-negative pathogens

Over the next five years, 15 international doctoral students will be trained at Saarland University and HIPS.

In the concept phase, scientists develop implementation strategies for metabolites from fungi and a new class of active substances against malaria

The floating Science Center will be anchored in Saarbrücken (near the Congresshalle in Bürgerpark) from August 5 to 8.

Researchers from Saarland receive millions in funding from Volkswagen Foundation

We warmly welcome Fabian and his team to HIPS.

Saarbrücken researchers optimize drug candidate against multi-resistant bacteria and parasites

New junior research group on single cell research at HIPS cooperates with Saarland University and Stanford University

HIPS scientists elucidate the biosynthesis of natural product Thioholgamide

Jerusalem, March 16 2022 - Terrapeutics Pharma (“Terrapeutics”) and the Helmholtz-Institute for Pharmaceutical Research Saarland (HIPS) are pleased to announce that they have…

Saarbrücken researchers develop drug candidates against hospital germs

Scientists at HIPS develop a screening tool for assessing bacterial bioavailability.

Claus-Michael Lehr wins the PHOENIX Pharmacy Science Award 2021

After five years as a junior professor at HIPS, Gregor Fuhrmann will take up a professorship in pharmaceutical biology at the Friedrich-Alexander-University Erlangen-Nuremberg…

Researchers from the Department of Microbial Natural Products improve the production of a new drug candidate.

International research alliance proposes strategy for the discovery and development of new active substances

The Alexander von Humboldt Foundation has selected Claus-Michael Lehr as a scout within the Henriette-Herz-Programme.This award allows him to select three young scientific…

On the occasion of World Tuberculosis Day, Jennifer Herrmann, scientist in the department Microbial Natural Products, talks about the epidemiology of the disease and her…

Saarbrücken researchers develop novel strategy for treating hospital germs

Scientists from the Microbial Natural Products department reveal how myxobacteria produce antimicrobial compounds.

Scientists from the Department of Microbial Natural Products discover a new class of natural products in an unusual myxobacterial strain

HIPS Director receives most important research award in Germany

The Federal Budget Committee has assured the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) funding of 47 million euros for the further expansion of the…

Team of Prof Anna Hirsch receives 1.46 million Euros in funding

Gregor Fuhrmann and two other HZI scientists receive million-euro funding from the European Research Council

HIPS research group leader develops drug candidates and diagnostics for bacterial infections

HIPS takes part in the “Living Therapeutic Materials” project

HIPS researchers decipher a step in the biosynthesis of an antibiotically active natural product

Anna K. H. Hirsch coordinates EU-funded training of new generation of researchers

Novel vehicles increase the efficiency of antibiotics against chronic infections

Bill & Melinda Gates Foundation funds collaboration of the HZI/HIPS with Evotec to develop new drug approaches for treating tuberculosis and malaria

The Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), Saarland University and the Leibniz Institute for New Materials enter into an interdisciplinary…

The European Federation of Medical Chemistry awarded HIPS researcher Anna Hirsch the Runner-Up Prize as Young Medicinal Chemist in Academia 2019

HIPS researcher Gregor Fuhrmann has received the Young Investigators Award of the Horst Böhme Foundation of the German Pharmaceutical Society